Advertisement

ITI Pharma and Healthcare Fund Direct Reinvestment Inc Dist cum Cap Wdrl INF00XX01BQ4

NAV / 1-Day Return
16.47 / -0.00%
Total Assets
2.0 Bil
Inception Date
Nov 11, 2021
Expense Ratio
0.470%
Fee Level
Load
Deferred
Category
India Fund Sector - Healthcare
Investment Style
Large Growth
Minimum Initial Investment
5,000
Status
Open
TTM Yield
0.00%
Turnover
62%



Holdings

Portfolio Holdings
# Long
# Short
Equity Holding
39 0
Bond Holding
0 0
Other Holding
2 0
Total Holding
41 0
Equity Holdings
39
Bond Holdings
0
Other Holdings
2
Total Holdings
41
% Assets in Top 10 Holdings
58
Reported Turnover %
61.96
As of 03 / 31 / 24
Women Directors %
24
Women Executives %
15
Holdings
% Portfolio Weight
First Bought
Market Value as of Feb 28, 2025
Cur Currency
Share Change %
1-Year Return
Forward P/E
Equity Star Rating
Economic Moat
ESG Risk Rating Assessment
Sector
15.86 Nov 30, 2021 318,460,000
INR Indian Rupee
5.19 Healthcare
6.26 Feb 28, 2022 125,644,000
INR Indian Rupee
21.01 Healthcare
6.06 Nov 30, 2021 121,605,000
INR Indian Rupee
60.28 Healthcare
5.67 Mar 31, 2022 113,863,000
INR Indian Rupee
56.38 Healthcare
5.02 Dec 31, 2022 100,885,000
INR Indian Rupee
3.01 Healthcare
4.65 Aug 31, 2023 93,428,000
INR Indian Rupee
1.87 Healthcare
4.23 Nov 30, 2021 84,966,000
INR Indian Rupee
33.20 Healthcare
4.00 Oct 31, 2024 80,238,000
INR Indian Rupee
20.20 Healthcare
3.35 Mar 31, 2022 67,338,000
INR Indian Rupee
-7.18 15.36 None Healthcare
2.95 May 31, 2023 59,214,000
INR Indian Rupee
6.24 Healthcare
Holdings as of Feb 28, 2025 | The top 41 largest holdings are available for display across Equity, Bond and Other.


© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top